BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 47 filers reported holding BIOTA PHARMACEUTIALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
Q2 2015 | $207,000 | -10.0% | 100 | 0.0% | 0.00% | – |
Q1 2015 | $230,000 | +2.7% | 100 | 0.0% | 0.00% | – |
Q4 2014 | $224,000 | -9.3% | 100 | 0.0% | 0.00% | – |
Q3 2014 | $247,000 | -13.3% | 100 | 0.0% | 0.00% | – |
Q2 2014 | $285,000 | -53.4% | 100 | 0.0% | 0.00% | – |
Q1 2014 | $611,000 | +45.8% | 100 | 0.0% | 0.00% | – |
Q4 2013 | $419,000 | +0.2% | 100 | 0.0% | 0.00% | – |
Q3 2013 | $418,000 | +21.2% | 100 | 0.0% | 0.00% | – |
Q2 2013 | $345,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 1,407,700 | $3,153,000 | 0.92% |
Broadfin Capital, LLC | 5,223,422 | $11,700,000 | 0.51% |
Avoro Capital Advisors LLC | 258,586 | $579,000 | 0.39% |
RA Capital Management | 1,378,770 | $3,088,000 | 0.33% |
BVF INC/IL | 435,900 | $976,000 | 0.19% |
Dominick & Dominick LLC | 150,166 | $336,000 | 0.17% |
TOWERVIEW LLC | 160,000 | $358,000 | 0.16% |
KNOTT DAVID M | 268,327 | $601,052,000 | 0.14% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $656,000 | 0.09% |
Baker Brothers Advisors | 1,106,910 | $2,479,000 | 0.02% |